Skip to main content

Your search for “Novel Treatment” returned 433 results

Combined Chemotherapy and Immunotherapy Shows Promise for Advanced Prostate Cancers

April 29, 2015

…cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.

UC San Diego Among First in Nation to Treat Brain Cancer with Novel Viral Vector

March 1, 2012

UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego Company, Tocagen Inc.

Novel Drug Prevents Amyloid Plaques, a Hallmark of Alzheimer’s Disease

March 2, 2021

Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.

New Cancer Council Combines Local Centers’ Strengths

March 6, 2013

…Research Institute. These singular enterprises have now formed a novel collaboration to leverage their distinct and combined resources and talents.

Why the Flu Vaccine Is Less Effective in the Elderly

December 15, 2015

…at protecting older individuals. More broadly, the findings reveal novel molecular signatures that could be used to predict which individuals are most likely to respond positively to vaccination.

Novel Therapeutic Agent for Pediatric Cancer Developed at UC San Diego in Clinical Trials

August 11, 2015

…and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer. The agent, named SF1126, acts by inhibiting the part of the cancer cell engine that promotes tumor angiogenesis and growth.

A Walk in her Flip Flops — El Centro Mayor Shares Story of Kidney Cancer

October 9, 2024

El Centro Mayor, Sylvia Marroquin, shares her journey with kidney cancer and how a clinical trial at UC San Diego Health saved her life.

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

May 16, 2022

COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.

UC San Diego Researchers Launch Combination Drug Trial to Eradicate B-Cell Malignancies

March 9, 2018

…effectiveness of a standard of care drug with a novel monoclonal antibody that target B-cell malignancies, which include leukemias and lymphomas.

UC San Diego Chemists Create the Ultimate Natural Sunscreen

May 17, 2017

Chemists, materials scientists and nanoengineers at UC San Diego have created what may be the ultimate natural sunscreen. In a paper published in the American Chemical Society journal ACS Central Science, they report the development of nanoparticles that mimic the behavior of natural melanosomes, melanin-producing cell structures that protect our…

Category navigation with Social links